Back
Beam Therapeutics Stock Price Chart
Sponsored
BEAM
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
BEAM
Beam Therapeutics
Last Price:
24.62
Seasonality Move:
42.3%
7 Day Trial
ALL ACCESS PASS
$
7
Access The Stock Grader Trading Tool From "The King Of Quants"
More details here...- The current trend is relatively stagnant and BEAM is experiencing selling pressure, which indicates risk of future bearish movement.
Beam Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.41 | Sell |
20-day SMA: | 24.76 | Sell |
50-day SMA: | 24.54 | Sell |
200-day SMA: | 26.78 | Sell |
8-day EMA: | 24.94 | Sell |
20-day EMA: | 24.97 | Sell |
50-day EMA: | 24.79 | Sell |
200-day EMA: | 26.05 | Sell |
Beam Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.19 | Buy |
Relative Strength Index (14 RSI): | 45.28 | Sell |
Chaikin Money Flow: | -643841 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.11 - 26.57) | Sell |
Bollinger Bands (100): | (22.91 - 27.69) | Sell |
Beam Therapeutics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Beam Therapeutics Stock
Is Beam Therapeutics Stock a Buy?
- Beam Therapeutics share price is 23.58 while BEAM 8-day simple moving average is 25.41, which is a Sell signal.
- The stock price of BEAM is 23.58 while Beam Therapeutics 20-day SMA is 24.76, which makes it a Sell.
- Beam Therapeutics 50-day simple moving average is 24.54 while BEAM share price is 23.58, making it a Sell technically.
- BEAM stock price is 23.58 and Beam Therapeutics 200-day simple moving average is 26.78, creating a Sell signal.
BEAM Technical Analysis vs Fundamental Analysis
Buy
52
Beam Therapeutics (BEAM)
is a Buy
Is Beam Therapeutics a Buy or a Sell?
-
Beam Therapeutics stock is rated a Buy
The current Beam Therapeutics [BEAM] share price is $23.58. The Score for BEAM is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
Beam Therapeutics Stock Info
Market Cap:
1.95B
Price in USD:
23.58
Share Volume:
1.01M
Beam Therapeutics 52-Week Range
52-Week High:
49.50
52-Week Low:
20.84
Buy
52
Beam Therapeutics (BEAM)
is a Buy
Beam Therapeutics Share Price Forecast
-
What is the Beam Therapeutics stock price today?
The Beam Therapeutics stock price is 23.58 USD today. -
Will BEAM stock go up or go down?
Beam Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Beam Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Beam Therapeutics is not overvalued.
Is Beam Therapeutics Stock a Buy?
- Beam Therapeutics share price is 23.58 while BEAM 8-day exponential moving average is 24.94, which is a Sell signal.
- The stock price of BEAM is 23.58 while Beam Therapeutics 20-day EMA is 24.97, which makes it a Sell.
- Beam Therapeutics 50-day exponential moving average is 24.79 while BEAM share price is 23.58, making it a Sell technically.
- BEAM stock price is 23.58 and Beam Therapeutics 200-day simple moving average is 26.05, creating a Sell signal.
Fundamental Analysis of Beam Therapeutics
Is Beam Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.58 per share, and a decrease next year of $0.04 per share.
Technical Analysis of Beam Therapeutics
Should I short Beam Therapeutics stock?
- BEAM Moving Average Covergence Divergence (MACD) indicator is 0.19, suggesting Beam Therapeutics is a Buy
- Beam Therapeutics Relative Strength Index (RSI) is 45.28, which suggest Beam Therapeutics is oversold
- The Bollinger Bands (25) for Beam Therapeutics is (22.11 - 26.57), which suggest Beam Therapeutics is a Sell
- The Bollinger Bands (100) for Beam Therapeutics is (22.91 - 27.69), which suggest Beam Therapeutics is a Sell
* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.